Literature DB >> 2566238

A survey of elderly new patients at a dermatology outpatient clinic.

N McFadden1, K O Hande.   

Abstract

A study of all new dermatitic out patients greater than 70 years of age, referred in the period January-June 1987 (257 patients), was undertaken to obtain information on the types of skin diseases and the dermatological outpatient services required in the case of the elderly. The group accounted for 14% of all new patients. The leading diagnoses were seborrheic keratosis (15.6%), basal cell carcinoma (13.6%), solar keratosis (13.2%), psoriasis (9.7%) and leg ulcer (9.3%). A skin biopsy was required in 27%, and surgical treatment in 31% of the group, compared with 12% and 16%, respectively, of all new patients during the same period. Consequently, the elderly group were more likely to require a follow-up appointment and tended to be more time-consuming outpatients.

Entities:  

Mesh:

Year:  1989        PMID: 2566238

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  4 in total

1.  Psoriasis in patients older than 65 years. A comparative study with younger adult psoriatic patients.

Authors:  R M Fernandez-Torres; S Paradela; E Fonseca
Journal:  J Nutr Health Aging       Date:  2012       Impact factor: 4.075

Review 2.  Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.

Authors:  Gil Yosipovitch; Mark B Y Tang
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 3.  Recognition and treatment of psoriasis. Special considerations in elderly patients.

Authors:  C Bonifati; M Carducci; A Mussi; L D'Auria; F Ameglio
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

4.  Detection of human papillomavirus DNA in nongenital seborrhoeic keratoses.

Authors:  D Tsambaos; A Monastirli; N Kapranos; S Georgiou; E Pasmatzi; A Stratigos; H Koutselini; H Berger
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.